Answers are grounded in this paper and cite their sources.
Background Adherence to antiretroviral therapy (ART) is an essential component in the global response to HIV/AIDS. Despite increased access to ART in Cameroon, maintaining adherence to ART remains a significant challenge, jeopardising progress toward the global 95‐95‐95 HIV treatment targets. Objectives To assess the level of adherence to ART and associated factors among people living with HIV at Yaounde Military Hospital in Cameroon. Methods A cross‐sectional study was conducted from January to June 2025 among people living with HIV (PLHIV) aged 10 years and above receiving ART at the Yaounde Military Hospital. A simple random sampling technique was employed, whereby all eligible participants presenting for ART refill during the study period were invited to participate. A total of 356 PLHIV were interviewed using a structured questionnaire. Adherence to ART was measured using pill count and viral suppression. Descriptive statistics summarised demographic and clinical variables, Chi‐square tests assessed associations between categorical variables, and logistic regression identified factors associated with adherence. Statistical significance was set at p < 0.05. Results The mean age of participants was 46.5 ± 15.1 years, ranging from 10 to 84 years, and the mean duration on ART was 9.4 ± 5.8 years, ranging from 0 to 24 years. An overall adherence rate, measured by pill count, was 86.0% (95% CI: 82.35–89.57), while out of 356 participants, 344 (96.6%; 95% CI: 94.7–98.3) were virally suppressed. Factors significantly associated with adherence included smoking (AOR = 5.27, 95% CI = 1.72–16.13, p = 0.004), male gender (AOR = 2.8, 95% CI = 1.12–7.31, p = 0.027) and ART adverse effects (AOR = 0.35, 95% CI = 0.14–0.87, p = 0.023). Conclusion ART adherence in this study fell below the UNAIDS optimal target of ≥ 95%. Factors such as smoking, male gender and ART adverse effects significantly influence adherence. Targeted interventions addressing these barriers are essential to optimise adherence and sustain progress toward the 95‐95‐95 HIV treatment targets in Cameroon.
No takes yet. Share an insight, caveat, or question.
Shang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: